Novartis Escapes Punitive Damages In Zometa Suit
Novartis Pharmaceuticals Corp. won't face punitive damages in an Ohio woman's lawsuit claiming the company's Zometa cancer drug causes bone damage, an Ohio federal judge ruled Thursday, finding that federal law...To view the full article, register now.
Already a subscriber? Click here to view full article